Apollomics Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants (NCT05367388) | Apollomics Inc. | 2022-05-20 |
| Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML (NCT05054543) | Apollomics Inc. | 2021-11-17 |
| APL-102 Capsule in Patients With Advanced Solid Tumors (NCT05055518) | Apollomics Inc. | 2021-08-02 |
| APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (NCT03175224) | Apollomics Inc. | 2017-09-27 |
Track Apollomics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.